Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

COVID-19 Vaccines, Therapies Would Get Billion-Dollar Manufacturing Platform Under House Bill

Mar 25 2020

• By Bowman Cox

Autumn Capital Hill Panorama — House looks to boost domestic pharma manufacturing

Related Content

The Quality Lowdown: Warning Letters, Nitrosamine Recalls And Sen. Warren's Generics Manufacturing Plan

Jan 23 2020

Buying The Coronavirus Vaccine: What Would A ‘Fair And Reasonable’ Price Be?

Mar 06 2020

Supply Chain Resilience Measures Included In Senate Coronavirus Bill

Mar 22 2020

Drug Shortage Legislation Gains Support As Coronavirus Threatens US Supplies

Mar 09 2020

Additional Topics

United States Coronavirus COVID-19 Legislation Manufacturing BioPharmaceutical

More from Legislation

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window